Literature DB >> 21716015

Attention deficit/hyperactivity disorder: is there a correlation between dopamine transporter density and cerebral blood flow?

Neivo da Silva1, Claudia M Szobot, Carlos E Anselmi, Andrea P Jackowski, Shih M Chi, Marcelo Q Hoexter, Osvaldo E Anselmi, Flavio Pechansky, Rodrigo A Bressan, Luis A Rohde.   

Abstract

Attention deficit/hyperactivity disorder (ADHD) is one of the most frequent behavioral problems in school-age children. Although the etiology remains unclear, the involvement of the dopaminergic system has been suggested by genetic studies that report an overexpression of the dopamine transporter (DAT) gene. In spite of these abnormalities being directly related to the decrease of dopamine (DA) in the striatum (STR), abnormalities in brain perfusion have also been observed in cortical-subcortical structures. Functional neuroimaging studies have suggested that the DA concentration may cause changes in the cerebral blood flow (CBF). The objective of our study was to evaluate the relationship between DAT density in STR and cortical-subcortical impairment in CBF. Based on the hypothesis that there is a correlation between DA availability and brain perfusion, we postulated that individuals with ADHD, with a higher DAT density in the basal ganglia, will have lower perfusion in the fronto-striatal-cerebellar networks. We used Tc-99m TRODAT-1 SPECT to measure DAT density and Tc-99m ECD SPECT to assess brain perfusion. Ten adolescents diagnosed with ADHD by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria were investigated. Analysis with Statistical Parametric Mapping 5 corrected for multiple comparisons, using small volume correction, showed a significant negative correlation between the DAT density in the STR and CBF in the cingulate gyrus, frontal lobe, temporal lobe, and cerebellum (pFDR <0.01). Our findings suggest that higher DAT density in the STR was associated with a decrease in the regional CBF in the cortical and subcortical attention network.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21716015     DOI: 10.1097/RLU.0b013e318219b49d

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  7 in total

Review 1.  The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.

Authors:  Stephen V Faraone
Journal:  Neurosci Biobehav Rev       Date:  2018-02-08       Impact factor: 8.989

Review 2.  Neuroimaging of attention-deficit/hyperactivity disorder: current neuroscience-informed perspectives for clinicians.

Authors:  Samuele Cortese; F Xavier Castellanos
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

3.  Dopaminergic polymorphisms associated with time-on-task declines and fatigue in the Psychomotor Vigilance Test.

Authors:  Julian Lim; Richard Ebstein; Chun-Yu Tse; Mikhail Monakhov; Poh San Lai; David F Dinges; Kenneth Kwok
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

4.  Upregulated GABA Inhibitory Function in ADHD Children with Child Behavior Checklist-Dysregulation Profile: 123I-Iomazenil SPECT Study.

Authors:  Shinichiro Nagamitsu; Yushiro Yamashita; Hitoshi Tanigawa; Hiromi Chiba; Hayato Kaida; Masatoshi Ishibashi; Tatsuyuki Kakuma; Paul E Croarkin; Toyojiro Matsuishi
Journal:  Front Psychiatry       Date:  2015-06-02       Impact factor: 4.157

5.  Alterations of cerebral perfusion and functional brain connectivity in medication-naïve male adults with attention-deficit/hyperactivity disorder.

Authors:  Ya-Wen Tan; Lu Liu; Yan-Fei Wang; Hai-Mei Li; Mei-Rong Pan; Meng-Jie Zhao; Fang Huang; Yu-Feng Wang; Yong He; Xu-Hong Liao; Qiu-Jin Qian
Journal:  CNS Neurosci Ther       Date:  2019-06-23       Impact factor: 5.243

6.  Altered Arginine/Nitric Oxide Pathway in Children Diagnosed Attention Deficit Hyperactivity Disorder, and the Effect of 10 Weeks Methylphenidate Treatment.

Authors:  Ebru Doneray; Kemal Utku Yazici; Ipek Percinel Yazici; Bilal Ustundag
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-05-31       Impact factor: 3.731

7.  The Loudness Dependence of Auditory Evoked Potentials is associated with the Symptom Severity and Treatment in Boys with Attention Deficit Hyperactivity Disorder.

Authors:  Eun Jin Park; Young-Min Park; Seung-Hwan Lee; Bongseog Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-08-31       Impact factor: 3.731

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.